Мероприятия

 

Фармакотерапия неинфекционной диареи
Автор: Е. Ушкалова   

 

magazine-vrach-2013-10-004

Фармакотерапия неинфекционной диареи

Обсуждаются вопросы эпидемиологии, этиологии, патогенеза и фармакотерапии неинфекционной диареи. Представлены данные клинических и эпидемиологических исследований об эффективности и безопасности лекарственных препаратов разных групп при диарее различного генеза.
Pharmacotherapy for noninfectious diarrhea
The paper discusses the epidemiology, etiology, pathogenesis, and pharmacotherapy of noninfectious diarrhea. It gives clinical and epidemiological data on the efficiency and safety of drugs from different groups to treat diarrhea of varying genesis.The paper discusses the epidemiology, etiology, pathogenesis, and pharmacotherapy of noninfectious diarrhea. It gives clinical and epidemiological data on the efficiency and safety of drugs from different groups to treat diarrhea of varying genesis.
Литература
1. Manatsathit S., Dupont H., Farthing M. et al. Guideline for the management of acute diarrhea in adults // J. Gastroenterol. Hepatol. – 2002; 17: 54–71.
2. Santosham M., Keenan E., Tulloch J. et al. Oral rehydration therapy for diarrhea: an example of reverse transfer of technology // Pediatrics. – 1997; 100: 10.
3. Gangarosa R., Glass R., Lew J. et al. Hospitalizations involving gastroenteritis in the United States, 1985 the special burden of the disease among the elderly // Am. J. Epidemiol. – 1992; 135: 281–90.
4. Bonis P., LaMont J., Rutgeerts P. et al. Approach to the adult with chronic diarrhea in developed countries. Uptodate June 2011. http://www.uptodate.com/contents/approach-to-the-adult-with-chronic-diarrhea-in-developed-countries?source=see_link
5. Fine K., Schiller L. AGA technical review on the evaluation and management of chronic diarrhea // Gastroenterology. – 1999; 116: 1464.
6. Preidis G., Hill C., Guerrant R. et al. Probiotics, Enteric and Diarrheal Diseases, and Global Health // Gastroenterology. – 2011; 140 (1): 8–14.
7. Li Z., Vaziri H. Treatment of chronic diarrhea // Best Pract. Res. Clin. Gastroenterol. – 2012; 26 (5): 677–87.
8. Kaiser L., Surawicz C. Infectious causes of chronic diarrhea // Best Pract. Res. Clin. Gastroenterol. – 2012; 26 (5): 563–71.
9. Lee S., Surawicz C. Infectious causes of chronic diarrhea // Gastroenterol. Clin. North Am. – 2001; 30: 679–92.
10. Juckett G., Trivedi R. Evaluation of chronic diarrhea // Am. Fam. Physician. – 2011; 84: 1119–26.
11. Белоусова E.А., Златкина А.Р. Синдром диареи в практике гастроэнтеролога: патофизиология и дифференцированный подход к лечению // Фарматека. – 2003; 10: 65–71.
12. Sellin J. The pathophysiology of diarrhea // Clin. Transplant. – 2001; 15 (4): 2–10.
13. Singal A., Reddy N., Powell D. Diarrhea Related to Non-neoplastic Endocrine Diseases. In: Diarrhea. Diagnostic and Therapeutic Advances. Edited by: S. Guandalini, H. Vaziri / Springer Science+Business Media, LLC, 2011; p. 357–78.
14. Парфенов А.И. Дифференциальная диагностика и лечение диареи // Справ. поликлин. врача. – 2004; 3 (4).
15. Reduced osmolarity oral rehydration salts (ORS) formulation - Report from a meeting of experts jointly organized by UNICEF and WHO. WHO/CAH/01.22
16. Gorospe E., Oxentenko A. Nutritional consequences of chronic diarrhea // Best Pract. Res. Clin. Gastroenterol. – 2012; 26 (5): 663–75.
17. American Gastroenterological Association. American Gastroenterological Association medical position statement: guideline for the evaluation and management of chronic diarrhea // Gastroenterology. – 1999; 116: 1461–3.
18. Schiller L. Chronic Diarrhea // Cur. Treat. Options Gastroenterol. – 2005; 8 (3): 259–66.
19. Baldi F., Bianco M., Nardone G. et al. Focus on acute diarrhoeal disease // World J. Gastroenterol. – 2009; 15, 3341–8.
20. Baker D. Loperamide: a pharmacological review // Rev. Gastroenterol. Disord. – 2007; 7 (3): 11–8.
21. Awouters F., Megens A., Verlinden M. et al. Loperamide. Survey of studies on mechanism of its antidiarrheal activity // Dig. Dis. Sci. – 1993; 38 (6): 977–95.
22. Ruppin H. Review: loperamide – a potent antidiarrhoeal drug with actions along the alimentary tract // Aliment. Pharmacol. Ther. – 1987; 1 (3): 179–90.
23. Hanauer S. The role of loperamide in gastrointestinal disorders // Rev. Gastroenterol. Disord. – 2008; 8 (1): 15–20.
24. Dalby-Payne J., Elliott E. Gastroenteritis in children // Clin. Evid (Online). – 2011; 2011: pii: 0314.
25. Trinkley K., Nahata M. Treatment of irritable bowel syndrome // J. Clin. Pharm. Ther. – 2011; 36 (3): 275–82.
26. Ford A., Vandvik P. Irritable bowel syndrome // Clin. Evid (Online). – 2012; 2012: pii: 0410.
27. Muehlbauer P., Thorpe D., Davis A. et al. Putting evidence into practice: evidence-based interventions to prevent, manage, and treat chemotherapy- and radiotherapy-induced diarrhea // Clin. J. Oncol. Nurs. – 2009; 13 (3): 336–41.
28. Pastrana T., Meißner W. Treatment of diarrhea with loperamide in palliative medicine. A systematic review // Schmerz. – 2013; 27 (2): 182–9.
29. Riddle M., Arnold S., Tribble D. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis // Clin. Infect. Dis. – 2008; 47 (8): 1007–14.
30. Ericsson C., Johnson P. Safety and efficacy of loperamide // Am. J. Med. – 1990; 88 (6A): 10–4.
31. Fraser N. Accidental poisoning deaths in British children 1958-77 // Br. Med. J. – 1980; 280 (6231): 1595–8.
32. Food and Drug Administration, HHS. Antidiarrheal drug products for over-the-counter human use; final monograph // Final rule. Fed. Regist. – 2003; 68 (74): 18869–82.
33. Kim-Jung L., Holquisti C., Phillips J. Kaopectate reformulation and upcoming labeling changes. DRUG TOPICS APRIL 19 2004 http://www.fda.gov/downloads/Drugs/DrugSafety/MedicationErrors/ucm080666.pdf
34. Dupont C., Vernisse B. Anti-diarrheal effects of diosmectite in the treatment of acute diarrhea in children: a review // Pediatr Drugs. – 2009; 11 (2): 89–99.
35. Guarino A., Lo V., Pirozzi M. Clinical role of diosmectite in the management of diarrhea // Expert Opin. Drug. Metab. Toxicol. – 2009; 5 (4): 433–40.
36. Hombrink J., Frohlich D., Glatzel M. et al. Prevention of radiation-induced diarrhea by smectite. Results of a double-blind randomized, placebo-controlled multicenter study // Strahlenther. Onkol. – 2000; 176 (4): 173–9.
37. Duffour J., Gourgou S., Seitz J. et al. Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer // Anticancer Res. – 2002; 22 (6B): 3727–31.
38. Amaro R., Poniecka A., Rogers A. Collagenous colitis treated successfully with bismuth subsalicylate // Dig. Dis. Sci. – 2000; 45 (7): 1447–50.
39. Fine K., Lee E. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis // Gastroenterology. – 1998; 114 (1): 29–36.
40. Labeling for oral and rectal over-the-counter drug products containing aspirin and nonaspirin salicylates; Reye's Syndrome warning // Final rule. Fed. Regist. – 2003; 68 (74): 18861–9.
41. Ruepert L., Quartero A., de Wit N. et al. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome // Cochrane Database Syst. Rev. – 2011; 8: CD003460.
42. Heather D., Howell L., Montana M. et al. Effect of a bulk-forming cathartic on diarrhea in tube-fed patients // Heart Lung. – 1991; 20 (4): 409–13.
43. Belknap D., Davidson L., Smith C. The effects of psyllium hydrophilic mucilloid on diarrhea in enterally fed patients // Heart Lung. – 1997; 26 (3): 229–37.
44. Smalley J., Klish W., Campbell M., Brown M. Use of psyllium in the management of chronic nonspecific diarrhea of childhood // J. Pediatr. Gastroenterol. Nutr. – 1982; 1 (3): 361–3.
45. Qvitzau S., Matzen P., Madsen P. Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium // Scand. J. Gastroenterol. – 1988; 23 (10): 1237–40.
46. Rachlis A., Gill J., Baril J. et al. Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study // HIV Clin. Trials. – 2005; 6 (4): 203–12.
47. Shibata C., Funayama Y., Fukushima K. et al. Effect of calcium polycarbophil on bowel function after restorative proctocolectomy for ulcerative colitis: a randomized controlled trial // Dig. Dis. Sci. – 2007; 52 (6): 1423–6.
48. Gattuso J., Kamm M. Adverse effects of drugs used in the management of constipation and diarrhea // Drug Saf. – 1994; 10 (1): 47–65.
49. Oberg K. Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors // Exp. Rev. Anticancer Ther. – 2009; 9 (5): 557–66.
50. Meyer C., O'Neal D., Connell W. et al. Octreotide treatment of severe diabetic diarrhea // Inter. Med. J. – 2003; 33 (12): 617–8.
51. Corbould A., Campbell J. Efficacy of octreotide but not long-acting somatostatin analogue for severe refractory diabetic diarrhea // Diabet. Med. – 2009; 26 (8): 828–9.
52. Long R., Adrian T., Bloom S. Somatostatin and the dumping syndrome // Br. Med. J. (Clin. Res. Ed.). – 1985; 290 (6472): 886–8.
53. Benson A. 3rd, Ajani J., Catalano R. et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea // J. Clin. Oncol. – 2004; 22 (14): 2918–26.
54. Richardson G., Dobish R. Chemotherapy induced diarrhea // J. Oncol. Pharm. Pract. – 2007; 13 (4): 181–98.
55. GarciaCompean D., Ramos Jimenez J., Guzman de la Garza F. et al. Octreotide therapy of large-volume refractory AIDS-associated diarrhea: a randomized controlled trial // AIDS. – 1994; 8 (11): 1563–7.
56. Ippoliti C., Champlin R., Bugazia N. et al. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies // J. Clin. Oncol. – 1997; 15 (11): 3350–4.
57. DiStefano P., Brown O. Biochemical correlates of morphine withdrawal. 2. Effects of clonidine // J. Pharmacol. Exp. Ther. –1985; 233 (2): 339–44.
58. Fedorak R., Field M., Chang E. Treatment of diabetic diarrhea with clonidine // Ann. Intern. Med. – 1985; 102 (2): 197–9.
59. Schiller L. Nutrition Management of Chronic Diarrhea and Malabsorption // Nutr. Clin. Pract. – 2006; 21 (1): 34–9.
60. Cheifetz A. Management of active Crohn disease // JAMA. – 2013; 309 (20): 2150–8.
61. Chande N., McDonald J., Macdonald J. Interventions for treating collagenous colitis // Cochrane Database Syst. Rev. – 2008; 2: CD003575.
62. Ianiro G., Cammarota G., Valerio L. et al. Microscopic colitis // World J. Gastroenterol. – 2012; 18 (43): 6206–15.
63. Nyhlin N., Bohr J., Eriksson S. et al. Systematic review: microscopic colitis // Pharmacol. Ther. – 2006; 23 (11): 1525–34.
64. Chande N., MacDonald J., McDonald J. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials // Am. J. Gastroenterol. – 2009; 104 (1): 235–41.
65. Münch A., Fernández-Bañares F., Munck L. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis // Aliment. Pharmacol. Ther. – 2013; 37 (8): 795–8.
66. Alfadda A., Storr M., Shaffer E. Eosinophilic colitis: epidemiology, clinical features, and current management // Ther. Adv. Gastroenterol. – 2011; 4 (5): 301–9.
67. Topkan E., Karaoglu A. Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma // Oncology. – 2006; 71 (5–6): 354–60.
68. Hamad A., Fragkos K., Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease // Clin. Nutr. – 2013; 32 (3): 353–60.
69. Gibson R., Keefe D., Lalla R. et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients // Support Care Cancer. – 2013; 21 (1): 313–26.
70. Wedlake L., Shaw C., Whelan K., Andreyev H. Systematic review: the efficacy of nutritional interventions to counteract acute gastrointestinal toxicity during therapeutic pelvic radiotherapy // Aliment. Pharmacol. Ther. – 2013; 37 (11): 1046–56.
71. Fuccio L., Guido A. Probiotics supplementation for the prevention of gastrointestinal radiation-induced side effects: the time is now // Am. J. Gastroenterol. – 2013; 108 (2): 277.
72. Reddy V., Patole S., Rao S. Role of probiotics in short bowel syndrome in infants and children--a systematic review // Nutrients. – 2013; 5 (3): 679–99.
73. Sartor R., LaMont T., Grover S. Probiotics for gastrointestinal diseases. Uptodate Feb 2013 http://www.uptodate.com/contents/probiotics-for-gastrointestinal-diseases.
74. Gareau M., Sherman P., Walker W. Probiotics and the gut microbiota in intestinal health and disease // Nat. Rev. Gastroenterol. Hepatol. – 2010; 7: 503–14.
75. Hardy H., Harris J., Lyon E. et al. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology // Nutrients. – 2013; 5 (6): 1869–912.
76. Rousseaux C., Thuru X., Gelot A. et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors // Nat. Med. – 2007; 13: 35.
77. Ritchie M., Romanuk T. A meta-analysis of probiotic efficacy for gastrointestinal diseases // PLoS One. – 2012; 7 (4): 34938.
78. Hempel S., Newberry S., Maher A. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis // J. Am. Med. Association. – 2012; 307: 1959–69.
79. Johnston B., Ma S., Goldenberg J. et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis // Ann. Int. Med. – 2012; 157: 878–88.
80. Videlock, E., Cremonini F. Meta-analysis: probiotics in antibiotic-associated diarrhea // Aliment. Pharm. Ther. – 2012; 35: 1355–69.
81. Avadhani A., Miley H. Probiotics for prevention of antibiotic-associated diarrhea and Clostridium difficile-associated disease in hospitalized adults--a meta-analysis // J. Am. Acad .Nurse Pract. – 2011; 23 (6): 269–74.
82. McFarland L. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease // Am. J. Gastroenterol. – 2006; 101 (4): 812–22.
83. Johnston B., Goldenberg J., Vandvik P. et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea // Cochrane Database Syst. Rev. – 2011; 11: CD004827.
84. Guandalini S. Probiotics for prevention and treatment of diarrhea // J. Clin. Gastroenterol. – 2011; 45: 149–53.
85. Rowland I., Capurso L., Collins K. et al. Current level of consensus on probiotic science – report of an expert meeting // Gut Microbes. – 2010; 1 (6): 436–9.
86. Floch M., Walker W., Madsen K. et al. Recommendations for probiotic use-2011 update // J. Clin. Gastroenterol. – 2011; 45: 168–71.
87. Wald A. Irritable bowel syndrome-diarrhoea // Best Pract. Res. Clin. Gastroenterol. – 2012; 26 (5): 573–80.
88. Moayyedi P., Ford A., Talley N. et al. Review The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review // Gut. – 2010; 59 (3): 325–32.
89. Ortiz-Lucas M., Tobнas A., Saz P. et al. Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis // Rev. Esp. Enferm. Dig. – 2013; 105 (1): 19–36.
90. Buzas G. Probiotics in gastroenterology – from a different angle // Orv. Hetil. – 2013; 154 (8): 294–304.
91. Storr M. Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management – an update 2013 // ISRN Gastroenterol. – 2013; 2013: 352718.
92. Pant C., Deshpande A., Larson A. et al. Diarrhea in Solid-Organ Transplant Recipients: A review of the evidence // Cur. Med. Res. Opin. – 2013 Jun 18. Epub. ahead of print.
93. Chen C., Walker W. Clinical applications of probiotics in gastrointestinal disorders in children // Nat. Med. J. India. – 2011; 24 (3): 153–60.
94. Haller D., Antoaine J., Bengmark S. et al. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome // J. Nutr. – 2010; 140 (3): 690–7.
95. Shiou S., Yu Y., Guo Y. et al. Synergistic Protection of Combined Probiotic Conditioned Media against Neonatal Necrotizing Enterocolitis-Like Intestinal Injury // PLoS One. – 2013; 8 (5): 65108.
96. Chapman T., Plosker G., Figgitt D. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases // Drugs. – 2006; 66 (10): 1371–87.
97. Schultz M., Lindström A. Rationale for probiotic treatment strategies in inflammatory bowel disease // Exp. Rev. Gastroenterol. Hepatol. – 2008; 2 (3): 337–55.
98. Корниенко Е.А. Современные принципы выбора пробиотиков // Дет. инфекции. – 2007; 3: 64–9.
99. Горелов А.В., Плоскирева А.А. Результаты сравнительного исследования по оценке эффективности и безопасности пробиотиков в стартовой терапии острых кишечных инфекций вирусной этиологии у детей // Инфекц. болезни. – 2013; 11 (1): 50–5.
100. Грачева Н.М. Современное лечение диарей различного генеза с использованием пробиотических препаратов // Инфекц. болезни. – 2007; 5 (1): 20–4.
101. Дорошина Е.А. Клинико-эпидемиологические особенности и вопросы терапии норовирусной инфекции у детей. Автореф. дис. ... канд. мед. наук. М., 2010; 24.
102. Шостакович-Корецкая Л.Р., Кривуша Е.Л., Чергинец А.В. Тактический подход к коррекции дисбиоза кишечника у детей пробиотическими препаратами. Опыт применения препарата Линекс // Укр. мед. журн. – 1999; 2: 61–4.
103. Зубадалашвили Н.Г., Махвиладзе М.А., Диасамидзе М.Т. и др. Сравнительная эффективность препаратов Лакто-G и Линекс при кишечном дисбактериозе у взрослых пациентов. Результаты рандомизирванного двойного слепого клинического исследования, у взрослых с хронической дисфункцией кишечника // Georgian Med. News. – 2009; 5 (170): 38–42.
104. Щербаков П.Л. и др. Антибиотикассоциированная диарея у детей – особенности коррекции микрофлоры // Вопр. практ. педиатр. – 2010; 5 (5): 44–51.
105. Осипенко М.Ф., Бикбулатова Е.А., Холин С.И. Пробиотики в лечении диарейного синдрома // Фарматека. – 2008; 13: 36–40.

 

 

 
Рассылка
Важно

→ Фармакопейные статьи


→ Медицинские архивы на службе современного врача


→ Перечень медицинских технологий

ЭКД архив

 

Баннер
Баннер
Баннер
Информационные партнеры:
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер
Баннер